Pulmonary arterial hypertension therapy business Morphogen-IX has been backed by Cambridge Enterprise and Cambridge Innovation Capital in a $23.3m round.

Commercialisation firm IP Group has invested in web data analytics business Import.io, continuing the involvement of its Imperial Innovations subsidiary, which had backed the company in 2016.

Microsoft, Samsung, BMW i Ventures, Robert Bosch Venture Capital and Dell Technologies Capital all invested in a round that valued the AI chipmaker at $1.7bn.

Biosimilar developer Alvotech has received $50m from Fuji Pharma through a development and commercialisation deal, valuing it at $1.19bn.

Cambridge textile dyeing spinout Colorifix has been backed by Cambridge Enterprise and retailer H&M in its first disclosed equity round.

Naspers co-led a $22.7m round that also included Axel Springer Digital Ventures, as Dott prepares to trial its scooter sharing service early next year.

Mitsubishi joins Anglo American Platinum in a second AP Ventures that will fund companies harnessing platinum group metals.

Jetstack, OpenCredo and Cygnacom are the first three recipients of cash from the cybersecurity technology producer's Machine Identity Protection Development Fund.

Goldman Sachs, Citigroup, Credit Suisse and existing investor JPMorgan Chase provided $17.5m of funding for the financial data software developer.

Parkwalk Advisors has invested an undisclosed sum in Cardiff ultrasound simulation technology developer MedaPhor through its Opportunities Fund.